Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Cardiovascular

Heart failure with preserved ejection fraction (HFpEF) can be challenging to diagnose, and recently risk scores have been developed to aid in diagnosis. For patients with chronic dyspnea, clinician-researchers in the Corrigan Minehan Heart Center sound a note of caution about using these scores including the HFA-PEFF algorithm and H2FPEF score to rule out HFpEF.

Featured In Neuroscience

Merit E. Cudkowicz, MD, MSc, chief of the Department Neurology and director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, discusses the Healey ALS Platform Trial, which aims to accelerate the discovery of new drug therapies for people with amyotrophic lateral sclerosis (ALS).

Featured In Urology

Douglas Middleton Dahl, MD, is chief of the Division of Urologic Oncology at Massachusetts General Hospital, as well as director of Robotic Surgery. In this video, he discusses his translational research on prostate cancer cells and explains how this work will advance patient care.

Featured In Rheumatology

Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.

Featured In Geriatrics and Palliative Care

A Massachusetts General Hospital palliative care training program offers training and resources to prompt and document more conversations about serious illness.

The Latest Ophthalmology Advances

The Department of Ophthalmology at Massachusetts Eye and Ear/Massachusetts General Hospital leads the ophthalmology community in developing and implementing outcome measures in every subspecialty area—setting the standard for transparency, accountability, and continued quality improvement in the field.

In the first study of its kind, Lucia Sobrin, MD, MPH, and John H. Kempen, MD, MPH, PhD, MHS, of the Massachusetts Eye and Ear/Mass General Hospital Department of Ophthalmology, and colleagues found a low risk of noninfectious uveitis among women using hormonal contraceptives or menopausal hormone replacement therapy.

Contributing Physicians

Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program

Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital

Advances Specialties


Lactobacillus species, which appear to protect against HIV infection and cervical cancer, are similarly abundant in vaginal samples from Black and whitepostmenopausal women, according to a molecular study by Caroline M. Mitchell, MD, MPH, and colleagues.


Miho J. Tanaka, MD, of the Department of Orthopedic Surgery, and colleagues found that 26% of patients presenting to general obstetric clinics had severe knee pain, which could impede their ability to remain active during pregnancy.

Pulmonary and Critical Care

In the first prospective study of its kind, a team led by Massachusetts General Hopsital found evidence that ivacaftor improves bone density and microarchitecture in children and adults with cystic fibrosis who have the G551D-CFTR mutation.

Education & Training Opportunities

April 21, 2021 - July 14, 2021

The Massachusetts General Hospital Corrigan Minehan Heart Center prepares future health care professionals and trains providers in innovative therapies and care. As part of these efforts, the center hosts regular Grand Rounds presentations from thought leaders and researchers on important cardiology topics. Cardiology Grand Rounds is open to all healthcare professionals.

January 25-30, 2021

The Society for Maternal-Fetal Medicine's Annual Meeting, The Pregnancy Meeting™, is the premier event for presenting and learning about cutting-edge science in obstetrics and provides participants the opportunity to connect with leaders and colleagues in maternal-fetal medicine. Learn more about the research presented by members of the Department of Obstetrics and Gynecology at Massachusetts General Hospital.

Clinical Trials

In Neuroscience

The study involves brain imaging including fMRI and PET-MR, an 8-week stress reduction intervention, and at-home practice. You will also complete daily migraine diaries.

In Neuroscience

Do you think about your appearance nonstop or find yourself stuck in front of the mirror? You may be eligible to participate in a smartphone study on day-to-day factors that contribute to distress in body dysmorphic disorder (BDD).